Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Machine Learning-Based Survival Analysis Reveals Prognostic Clinical and Genetic Insights for Patients with Cutaneous T-Cell Lymphoma

Blood (2023) 142 (Supplement 1): 1715.

https://doi.org/10.1182/blood-2023-190775

Published: 2023

Journal Articles

Tub-010, a Novel Antibody-Drug-Conjugate with Reduced Nonspecific Toxicity Profile Based on Tub-Tag Technology Widens the Therapeutic Window for the Treatment of CD30+ Malignancies

Marcus Gerlach, Saskia Schmitt, Philipp Cyprys, Marc-André Kasper, Isabelle Mai, Maarten H. Vermeer, Steven M. Horwitz, Guenter R Fingerle-Rowson, Annette Vogl, Dominik Schumacher, Jonas Helma-Smets

Blood (2022) 140 (Supplement 1): 9397–9398.

https://doi.org/10.1182/blood-2022-158681

Published: 2022

Journal Articles

Genetic and epigenetic insights into cutaneous T-cell lymphoma

Cornelis P. Tensen, Koen D. Quint, Maarten H. Vermeer

Blood (2022) 139 (1): 15–33.

https://doi.org/10.1182/blood.2019004256

Published: 2022

Journal Articles

Improved Sézary cell detection and novel insights into immunophenotypic and molecular heterogeneity in Sézary syndrome

Safa Najidh, Cornelis P. Tensen, Alita J. van der Sluijs-Gelling, Cristina Teodosio, Davy Cats, Hailiang Mei, Thomas B. Kuipers, Jacoba J. Out-Luijting, Willem H. Zoutman, Thorbald van Hall, Alberto Orfao, Julia Almeida, Jacques J. M. van Dongen, Maarten H. Vermeer

Blood (2021) 138 (24): 2539–2554.

https://doi.org/10.1182/blood.2021012286

Published: 2021

Includes: Supplemental data

Journal Articles

Characterization and Outcomes in Patients with Mogamulizumab-Associated Skin Reactions in the MAVORIC Trial

Amy C.M. Musiek, MD, Sean Whittaker, MD, Steven M. Horwitz, MD, Martine Bagot, MD PhD, Auris Huen, MD PharmD, David C. Fisher, MD, Paul Haun, MD MSc, Maarten H. Vermeer, MD PhD, Takahiro Ito, MSc, Karen Dwyer, BA, Fiona Herr, PhD, Youn H. Kim, MD

Blood (2020) 136 (Supplement 1): 23–24.

https://doi.org/10.1182/blood-2020-141041

Published: 2020

Journal Articles

Outcomes of rare patients with a primary cutaneous CD30 + lymphoproliferative disorder developing extracutaneous disease

Rutger C. Melchers, Rein Willemze, Joost S. P. Vermaat, Patty M. Jansen, Laurien A. Daniëls, Hein Putter, Marcel W. Bekkenk, Ellen R. M. de Haas, Barbara Horvath, Michelle M. van Rossum, Cornelus J. G. Sanders, Joep C. J. M. Veraart, Maarten H. Vermeer, Koen D. Quint

Blood (2020) 135 (10): 769–773.

https://doi.org/10.1182/blood.2019002799

Published: 2020

Includes: Supplemental data

Journal Articles

Antibiotics can improve CTCL

Maarten H. Vermeer

Blood (2019) 134 (13): 1000–1001.

https://doi.org/10.1182/blood.2019002236

Published: 2019

Journal Articles

High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma

Blood (2018) 131 (18): 2086–2089.

https://doi.org/10.1182/blood-2017-12-822817

Published: 2018

Includes: Supplemental data

Journal Articles

First-in-Human, Multicenter Phase I Study of IPH4102, First-in-Class Humanized Anti-KIR3DL2 Monoclonal Antibody, in Relapsed/Refractory Cutaneous T-Cell Lymphomas: Preliminary Safety, Exploratory and Clinical Activity Results

Blood (2016) 128 (22): 1826.

https://doi.org/10.1182/blood.V128.22.1826.1826

Published: 2016

Journal Articles

Antigen-Independent, Autonomous B-Cell Receptor Signaling As a Dominant Candidate Oncogenic Mechanism in ABC DLBCL

Marvyn T. Koning, BSc, Rudolf Übelhart, PhD, Arjen H.G. Cleven, PhD, Willem H. Zoutman, BSc, Sander A.J. van der Zeeuw, BSc, Philip Kluin, MD PhD, Marieke Griffioen, PhD, Cornelis P. Tensen, PhD, Maarten H. Vermeer, MD PhD, Rein Willemze, MD PhD, Szymon M. Kielbasa, PhD, Marcelo A. Navarrete, MD PhD, Hassan Jumaa, PhD, Hendrik Veelken, MD PhD

Blood (2016) 128 (22): 778.

https://doi.org/10.1182/blood.V128.22.778.778

Published: 2016

Journal Articles

The B-Cell Receptor of Primary Cutaneous Follicle Center Lymphoma: Implications for Pathogenesis

Marvyn T. Koning, BSc, Sander A.J. van der Zeeuw, BSc, Willem H. Zoutman, BSc, Maarten H. Vermeer, MD PhD, Rein Willemze, MD PhD, Hendrik Veelken, MD PhD, Cornelis P. Tensen, PhD

Blood (2016) 128 (22): 4136.

https://doi.org/10.1182/blood.V128.22.4136.4136

Published: 2016

Journal Articles

Loss of Pigh Expression Frequently Results in a GPI-Negative Subclone Lacking CD52 Membrane Expression, Conferring Alemtuzumab Resistance to B Cell Acute Lymphoblastic Leukemia

Floris C. Loeff, Kevin Rijs, Willem H. Zoutman, Esther H.M. Egmond, Maarten H. Vermeer, MD PhD, J.H. Frederik Falkenburg, MD PhD, Constantijn J.M. Halkes, MD PhD, Inge Jedema, PhD

Blood (2015) 126 (23): 1435.

https://doi.org/10.1182/blood.V126.23.1435.1435

Published: 2015

Journal Articles

The Mutational Landscape of CTCL and Sezary Syndrome

Teresa Palomero, PhD, Ana Carolina da Silva Almeida, PhD, Francesco Abate, PhD, Hossein Khiabanian, PhD, Estela Martinez-Escala, MD, Joan Guitart, MD, Cornelis P Tensen, MD, Maarten H. Vermeer, MD PhD, Raul Rabadan, PhD, Adolfo A. Ferrando, MD PhD

Blood (2015) 126 (23): 573.

https://doi.org/10.1182/blood.V126.23.573.573

Published: 2015

Journal Articles

Limited effect of chemotherapy in cutaneous lymphoma

Maarten H. Vermeer, Rein Willemze

Blood (2015) 125 (1): 4–5.

https://doi.org/10.1182/blood-2014-11-609305

Published: 2015

Journal Articles

Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases

Marchina F. Benner, Patty M. Jansen, Maarten H. Vermeer, Rein Willemze

Blood (2012) 119 (7): 1643–1649.

https://doi.org/10.1182/blood-2011-08-376319

Published: 2012

Journal Articles

EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma

Blood (2011) 118 (15): 4024–4035.

https://doi.org/10.1182/blood-2011-05-351346

Published: 2011

Journal Articles

MicroRNA expression in Sézary syndrome: identification, function, and diagnostic potential

Erica Ballabio, Tracey Mitchell, Marloes S. van Kester, Stephen Taylor, Heather M. Dunlop, Jianxiang Chi, Isabella Tosi, Maarten H. Vermeer, Daniela Tramonti, Nigel J. Saunders, Jacqueline Boultwood, James S. Wainscoat, Francesco Pezzella, Sean J. Whittaker, Cornelius P. Tensen, Christian S. R. Hatton, Charles H. Lawrie

Blood (2010) 116 (7): 1105–1113.

https://doi.org/10.1182/blood-2009-12-256719

Published: 2010

Includes: Supplemental data

Journal Articles

Oncogenomic analysis of mycosis fungoides reveals major differences with Sézary syndrome

Remco van Doorn, Marloes S. van Kester, Remco Dijkman, Maarten H. Vermeer, Aat A. Mulder, Karoly Szuhai, Jeroen Knijnenburg, Judith M. Boer, Rein Willemze, Cornelis P. Tensen

Blood (2009) 113 (1): 127–136.

https://doi.org/10.1182/blood-2008-04-153031

Published: 2009

Includes: Supplemental data

Journal Articles

Genome Wide Analysis of 41 Mycosis Fungoides Tumor Stage Using Array Comparative Genomic Hybridization Technology.

Blood (2008) 112 (11): 1769.

https://doi.org/10.1182/blood.V112.11.1769.1769

Published: 2008

Journal Articles

European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas

Nancy J. Senff, Evert M. Noordijk, Youn H. Kim, Martine Bagot, Emilio Berti, Lorenzo Cerroni, Reinhard Dummer, Madeleine Duvic, Richard T. Hoppe, Nicola Pimpinelli, Steven T. Rosen, Maarten H. Vermeer, Sean Whittaker, Rein Willemze

Blood (2008) 112 (5): 1600–1609.

https://doi.org/10.1182/blood-2008-04-152850

Published: 2008

NARROW

Machine Learning-Based Survival Analysis Reveals Prognostic Clinical and Genetic Insights for Patients with Cutaneous T-Cell Lymphoma

Tub-010, a Novel Antibody-Drug-Conjugate with Reduced Nonspecific Toxicity Profile Based on Tub-Tag Technology Widens the Therapeutic Window for the Treatment of CD30+ Malignancies

Genetic and epigenetic insights into cutaneous T-cell lymphoma

Improved Sézary cell detection and novel insights into immunophenotypic and molecular heterogeneity in Sézary syndrome

Characterization and Outcomes in Patients with Mogamulizumab-Associated Skin Reactions in the MAVORIC Trial

Outcomes of rare patients with a primary cutaneous CD30 + lymphoproliferative disorder developing extracutaneous disease

Antibiotics can improve CTCL

High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma

First-in-Human, Multicenter Phase I Study of IPH4102, First-in-Class Humanized Anti-KIR3DL2 Monoclonal Antibody, in Relapsed/Refractory Cutaneous T-Cell Lymphomas: Preliminary Safety, Exploratory and Clinical Activity Results

Antigen-Independent, Autonomous B-Cell Receptor Signaling As a Dominant Candidate Oncogenic Mechanism in ABC DLBCL

The B-Cell Receptor of Primary Cutaneous Follicle Center Lymphoma: Implications for Pathogenesis

Loss of Pigh Expression Frequently Results in a GPI-Negative Subclone Lacking CD52 Membrane Expression, Conferring Alemtuzumab Resistance to B Cell Acute Lymphoblastic Leukemia

The Mutational Landscape of CTCL and Sezary Syndrome

Limited effect of chemotherapy in cutaneous lymphoma

Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases

EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma

MicroRNA expression in Sézary syndrome: identification, function, and diagnostic potential

Oncogenomic analysis of mycosis fungoides reveals major differences with Sézary syndrome

Genome Wide Analysis of 41 Mycosis Fungoides Tumor Stage Using Array Comparative Genomic Hybridization Technology.

European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only